keyword
https://read.qxmd.com/read/38510891/transcatheter-aortic-valve-replacement-tavr-versus-surgical-aortic-valve-replacement-savr-a-review-on-the-length-of-stay-cost-comorbidities-and-procedural-complications
#21
REVIEW
Jonathan Kermanshahchi, Birpartap Thind, Gabriel Davoodpour, Megan Hirsch, Jeff Chen, Akshay J Reddy, Zeyu Yu, Benjamin E Falkenstein, Daryoush Javidi
This review provides an in-depth analysis of the effect of length of stay (LOS), comorbidities, and procedural complications on the cost-effectiveness of transcatheter aortic valve replacement (TAVR) in comparison to surgical aortic valve replacement (SAVR). We found that the average LOS was shorter for patients undergoing TAVR, contributing to lower average costs associated with the procedure, although the LOS varied between patients due to the severity of illness and comorbidities present. TAVR has also been found to improve the quality of life for patients receiving aortic valve replacement compared to SAVR...
February 2024: Curēus
https://read.qxmd.com/read/38509415/detecting-aortic-valve-stenosis-based-on-the-non-invasive-blood-pressure%C3%A2-waveform-a-proof-of-concept-study
#22
JOURNAL ARTICLE
Eline Kho, Jimmy Schenk, Alexander P J Vlaar, Marije M Vis, Marije Wijnberge, Lotte B Stam, Martijn van Mourik, Harald T Jorstad, Henning Hermanns, Berend E Westerhof, Denise P Veelo, Bjorn J P van der Ster
The incidence of aortic valve stenosis (AoS) increases with age, and once diagnosed, symptomatic severe AoS has a yearly mortality rate of 25%. AoS is diagnosed with transthoracic echocardiography (TTE), however, this gold standard is time consuming and operator and acoustic window dependent. As AoS affects the arterial blood pressure waveform, AoS-specific waveform features might serve as a diagnostic tool. Aim of the present study was to develop a novel, non-invasive, AoS detection model based on blood pressures waveforms...
March 20, 2024: GeroScience
https://read.qxmd.com/read/38505020/optimal-antithrombotic-strategy-following-valve-in-valve-transcatheter-aortic-and-mitral-valve-replacement
#23
REVIEW
Maximilian Reisinger, Polydoros N Kampaktsis, Tanush Gupta, Isaac George
The treatment of aortic and mitral valve disease requiring replacement has shifted to an increasing use of bioprosthetic heart valves. Due to their limited durability, there is a growing need for reintervention in the setting of failing bioprosthesis. Even though the gold standard for the treatment of failed bioprosthesis remains surgical repair or replacement, valve-in-valve (ViV) transcatheter aortic and mitral valve replacement have emerged as safe and effective alternatives for patients who are at high or prohibitive risk for surgery...
February 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38504317/high-risk-of-coronary-artery-obstruction-during-tavr-how-to-avoid-it
#24
JOURNAL ARTICLE
Jose R Gayosso-Ortíz, Juan F Garcia-Garcia, Jose Alfredo Merino-Rajme, Roberto Muratalla-González, Juan C Fuentes-Moreno, Arnoldo S Jiménez-Valverde, Marco A Alcantara-Melendez, Heberto Aquino-Bruno
BACKGROUND: Coronary artery obstruction after percutaneous aortic replacement is a complication with high short-term mortality secondary to the lack of timely treatment. There are various predictors of coronary obstruction prior to valve placement such as the distance from the ostia, the degree of calcification, the distance from the sinuses; In such a situation some measures must be taken to prevent and treat coronary obstruction. CASE PRESENTATION: An 84-year-old male, with severe aortic stenosis and high surgical risk, who was treated with TAVR...
March 19, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38502723/redo-tavr-feasibility-after-sapien-3-stratified-by-implant-depth-and-commissural-alignment-a-ct-simulation-study
#25
JOURNAL ARTICLE
Anoop N Koshy, Gilbert H L Tang, Sahil Khera, Manish Vinayak, Megan Berdan, Sneha Gudibendi, Amit Hooda, Lucy Safi, Stamatios Lerakis, George D Dangas, Samin K Sharma, Annapoorna S Kini, Parasuram Krishnamoorthy
BACKGROUND: Redo-transcatheter aortic valve replacement (TAVR) can pin the index transcatheter heart valve leaflets open leading to sinus sequestration and restricting coronary access. The impact of initial implant depth and commissural alignment on redo-TAVR feasibility is unclear. We sought to determine the feasibility of redo-TAVR and coronary access after SAPIEN 3 (S3) TAVR stratified by implant depth and commissural alignment. METHODS: Consecutive patients with native valve aortic stenosis were evaluated using multidetector computed tomography...
March 2024: Circulation. Cardiovascular Interventions
https://read.qxmd.com/read/38499650/transcatheter-aortic-valve-replacement-in-patients-with-severe-aortic-stenosis-reduced-the-frequency-of-intradialytic-hypotension
#26
JOURNAL ARTICLE
Makoto Saigan, Masaki Miyasaka, Tasuku Nagasawa, Masataka Taguri, Natsuko Satomi, Manami Watahiki, Masaki Nakashima, Yusuke Enta, Yusuke Toki, Yoshiko Munehisa, Jun Ito, Yukihiro Hayatsu, Norio Tada
Intradialytic hypotension (IDH) is a common complication during hemodialysis that increases cardiovascular morbidity and mortality. Aortic stenosis (AS) is a cause of IDH. Transcatheter aortic valve replacement (TAVR) has become an established treatment for patients with severe AS. However, whether TAVR reduce the frequency of IDH has not been investigated. This study aims to verify the efficacy of TAVR for reduction of the frequency of IDH. Consecutive hemodialysis patients who underwent TAVR at Sendai Kosei Hospital from February 2021 to November 2021 with available records 1 month before and 3 months after TAVR were included in the study...
March 18, 2024: Scientific Reports
https://read.qxmd.com/read/38497685/incidence-and-risk-factors-of-acute-kidney-injury-after-transcatheter-aortic%C3%A2-valve-replacement
#27
JOURNAL ARTICLE
Zhenjian Xu, Xin Zhou, Hui Yang, Qiuju Chen, Guangxuan Luo, Shichun Cai, Anping Xu
PURPOSE: Acute kidney injury (AKI) is a common early complication secondary to transcatheter aortic valve replacement (TAVR). Studies on the incidence and risk factors for AKI after TAVR surgery are limited to date. Here, we retrospectively analyzed the incidence and risk factors for AKI after TAVR surgery in our hospital. MATERIALS AND METHODS: Patients who underwent TAVR surgery at our hospital from November 2017 to February 2023 were selected. AKI was defined using the 2012 KDIGO definition and staging criteria...
March 18, 2024: Clinical Nephrology
https://read.qxmd.com/read/38496184/successful-rescue-transaortic-valve-replacement-using-edwards-sapien-3-following-failed-evolut-r-implantation-in-a-degenerated-surgical-bioprosthesis-a-case-report
#28
Victor H Molina-Lopez, Eduardo Partida-Rodriguez, Jaime Rivera-Babilonia, Luis Rodriguez-Ospina
This study examines a complex scenario of structural valve degeneration (SVD) in a high surgical-risk patient with a previously implanted 25 mm Carpentier-Edwards (CE) Perimount Magna Ease 3300 (Irvine, CA: Edwards Lifesciences) surgical bioprosthetic valve (SAV), the patient presented with both paravalvular leak (PVL) and central prosthetic valve insufficiency (PVI). The patient was considered for a transaortic valve-in-valve (ViV) intervention with a self-expanding 29 mm Evolut R valve (Minneapolis, MN: Medtronic)...
February 2024: Curēus
https://read.qxmd.com/read/38495939/structural-heart-disease-review-of-tavr-in-low-risk-patients-importance-of-lifetime-management
#29
REVIEW
Mohamad B Moumneh, Abdulla A Damluji, Andras W Heslop, Matthew W Sherwood
No abstract text is available yet for this article.
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38490897/carbon-footprint-of-total-intravenous-and-inhalation-anesthesia-in-the-transcatheter-aortic-valve-replacement-procedure
#30
JOURNAL ARTICLE
Lei Yang, Joshua Hubert, Samwel Gitundu, Ethan Brovman, Frederick Cobey
OBJECTIVES: To quantify and compare the emissions for deep sedation with total intravenous anesthesia (TIVA) and general anesthesia with inhaled agents during the transcatheter aortic valve replacement procedure. DESIGN: A retrospective study. SETTING: A tertiary hospital in Boston, Massachusetts. PARTICIPANTS: The anesthesia records of 604 consecutive patients who underwent the transcatheter aortic valve replacement procedure between January 1, 2018, and March 31, 2022, were reviewed and analyzed...
February 22, 2024: Journal of Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/38489572/snare-technique-to-facilitate-tall-in-short-redo-tavr
#31
JOURNAL ARTICLE
Craig Basman, Sung-Han Yoon, Vladimir Jelnin, Ryan Kaple
An 82-year-old man with a prior history of transcatheter aortic valve replacement (TAVR) with a 23-mm balloon-expandable transcatheter heart valve (THV) presented with bioprosthetic stenosis.
March 14, 2024: Journal of Invasive Cardiology
https://read.qxmd.com/read/38489568/hemodynamic-performance-of-self-expandable-transcatheter-aortic-valve-replacement-systems-during-valve-deployment
#32
JOURNAL ARTICLE
Alberto Alperi, Cesar Moris, Raquel Del Valle, Isaac Pascual, Paula Antuna, Marcel Almendárez, Daniel Hernández-Vaquero, Jose Luis Betanzos, Josep Rodés-Cabau, Pablo Avanzas
OBJECTIVES: Little is known about valve hemodynamic performance during the Evolut and Neo deployment course. We aimed to evaluate transvalvular mean and peak-to-peak gradients over several intraprocedural timepoints during TAVR with Evolut PRO+ (Medtronic) and Neo (Boston Scientific) systems. METHODS: This was single-center pilot sub-study from the SavvyWire EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI) trial. Participants received either the Evolut PRO+ or Neo for native valve severe aortic stenosis and the SavvyWire (OpSens Medical) was used for device delivery, pacing, and continuous left ventricular and aortic pressure measurements...
March 13, 2024: Journal of Invasive Cardiology
https://read.qxmd.com/read/38488066/diastolic-dysfunction-and-clinical-outcomes-after-transcatheter-or-surgical-aortic-valve-replacement-in-patients-with-atypical-aortic-valve-stenosis
#33
JOURNAL ARTICLE
Rashad J Belin, Travis B Desa, Igor Wroblewski, Cara Joyce, Anthony Perez-Tamayo, Jeffrey Schwartz, Lowell H Steen, John J Lopez, Bruce E Lewis, Ferdinand S Leya, Michael Tuchek, Mamdouh Bakhos, Verghese Mathew
BACKGROUND: Diastolic dysfunction is a predictor of poor outcomes in many cardiovascular conditions. At present, it is unclear whether diastolic dysfunction predicts adverse outcomes in patients with atypical aortic stenosis who undergo aortic valve replacement (AVR). METHODS: Five hundred and twenty-three patients who underwent transcatheter AVR (TAVR) (n = 303) and surgical AVR (SAVR) (n = 220) at a single institution were included in our analysis...
April 1, 2024: Journal of Cardiovascular Medicine
https://read.qxmd.com/read/38485598/editorial-the-carotid-highway-navigating-towards-safer-tavr-access-for-patients
#34
EDITORIAL
Philippe Taieb, Israel M Barbash
No abstract text is available yet for this article.
March 11, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38481647/late-onset-prosthetic-aortic-valve-stenosis-caused-by-pannus-formation
#35
Nicholas Roma, Kashyap Shah, Ketul Patel, Joshua Elmer, Bruce Ferraro, Prarthana Patel, Michael Durkin
UNLABELLED: Transcatheter aortic valve replacement (TAVR) is a less invasive alternative to an open surgical aortic valve replacement (SAVR) for treating severe symptomatic aortic stenosis. Despite gaining widespread acceptance and approval for use in patients with high, moderate, and low surgical risk, the increasing use of TAVR has raised concerns about potential short- and long-term complications. We present the case of a 69-year-old female who underwent TAVR and subsequently presented to our outpatient cardiology clinic with progressively worsening dyspnea, orthopnea, and paroxysmal nocturnal dyspnea two years after the procedure...
March 2024: Journal of Cardiology Cases
https://read.qxmd.com/read/38479969/big-picture-of-tavr-in-small-annuli-what-matters-most
#36
EDITORIAL
Naoki Misumida, Charanjit S Rihal
No abstract text is available yet for this article.
March 11, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38479967/tavr-procedure-related-stroke-when-the-safety-net-fails
#37
EDITORIAL
Paul Guedeney, Olivier Barthelemy, Gilles Montalescot
No abstract text is available yet for this article.
March 11, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38479966/the-impact-of-cerebral-embolic-protection-devices-on-characteristics-and-outcomes-of-stroke-complicating-tavr
#38
MULTICENTER STUDY
Amos Levi, Matthias Linder, Moritz Seiffert, Guy Witberg, Thomas Pilgrim, Daijiro Tomii, Yeela Tamlor Barkan, Nicolas M Van Mieghem, Rik Adrichem, Pablo Codner, David Hildick-Smith, Sandeep Arunothayaraj, Leor Perl, Ariel Finkelstein, Itamar Loewenstein, Ole De Backer, Rani Barnea, Giuseppe Tarantini, Luca Nai Fovino, Hana Vaknin-Assa, Darren Mylotte, Max Wagener, John G Webb, Mariama Akodad, Antonio Colombo, Antonio Mangieri, Azeem Latib, Faraj Kargoli, Francesco Giannini, Alfonso Ielasi, Lars Søndergaard, Itay Aviram, Tsahi T Lerman, Mark Kheifets, Eitan Auriel, Ran Kornowski
BACKGROUND: Acute ischemic stroke remains a serious complication of transcatheter aortic valve replacement (TAVR). Cerebral embolic protection devices (CEPD) were developed to mitigate the risk of acute ischemic stroke complicating TAVR (AISCT). However, the existing body of evidence does not clearly support CEPD efficacy in AISCT prevention. OBJECTIVES: In a cohort of patients with AISCT, we aimed to compare the characteristics and outcomes of patients who have had unprotected TAVR (CEPD-) vs CEPD-protected TAVR (CEPD+)...
March 11, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38472629/cerebral-embolic-protection-devices-for-transcatheter-aortic-valve-replacement-review-of-the-literature-and-future-perspectives
#39
REVIEW
Spencer Ng, Taylor Cunningham, John P Vavalle
PURPOSE OF REVIEW: Transcatheter aortic valve replacement (TAVR) has been a revolutionary therapy in the treatment of aortic valve stenosis. The risk of stroke associated with TAVR has decreased significantly since its introduction; however, it remains a devastating complication when it does occur. RECENT FINDINGS: Many of the strokes associated with TAVR occur peri-procedurally and are thought to be due to embolic debris entering the cerebrovascular circulation...
March 12, 2024: Current Cardiology Reports
https://read.qxmd.com/read/38471650/outcomes-for-patients-undergoing-transcatheter-aortic-valve-replacement-with-ascending-aorta-dilation
#40
JOURNAL ARTICLE
Dejing Feng, Jie Zhao, Guannan Niu, Yuxuan Zhang, Can Wang, Yang Chen, Zheng Zhou, Hongliang Zhang, Zhenyan Zhao, Yunqing Ye, Zhe Li, Haiyan Xu, Moyang Wang, Yongjian Wu
BACKGROUND: We aim to compare the short and long-term outcomes for aortic stenosis (AS) patients undergone TAVR with and without ascending aorta dilation (AAD). METHODS: Consecutive patients diagnosed with native severe AS who underwent TAVR from September 2012 to September 2021 were enrolled. They were stratified into the moderate/severe dilation group (greatest ascending aorta width ≥ 45 mm) and the non/mild dilation group. Survival outcomes were illustrated using Kaplan-Meier curves and evaluated with the log-rank test...
March 10, 2024: International Journal of Cardiology
keyword
keyword
5226
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.